According to the report titled ‘Asia Pacific Vascular Graft Market Forecast 2027 By Raw Material, By Application, By End-use, Research Report, Country Outlook, COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share’, available with MarketStudyReport, Asia Pacific vascular graft market is expected to garner massive revenues by the year 2027.
 

Rise in geriatric population, particularly in countries such as China and India where the death rate is lower with longer lifespan, has resulted in a consequent increase in cases of chronic diseases such as thoracic & abdominal aortic aneurysm, diabetes, and cardiovascular diseases, which is propelling the growth of Asia Pacific vascular graft market. In this regard, sources claim that the Asia Pacific region accounts for 60% of all diabetic patients worldwide.
 

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4037686/
 

Furthermore, higher pervasiveness of kidney failure among the populace, in consort with technological innovations in the field are creating lucrative opportunities for the businesses in this domain.
 

Despite the optimistic outlook, a shortage of skilled professionals in developing countries, alongside the risk of vascular graft infections will likely impede industry development in the coming years.
 

Based on the application spectrum, Asia Pacific vascular graft market share from peripheral vascular repair was valued at USD 121.2 million in 2020 and is anticipated to expand steadily over the analysis period, due to a spike in cases of Peripheral Arterial Disease (PAD) in the youth demographic, and fewer complications associated with using vascular grafts in the surgery.
 

Speaking of raw material ambit, polyester segment is predicted to grow at 7.5% CAGR through 2027, attributed to its ability to act as a biological seal with high compatibility with patients' blood leading to prevention of infections. Also, high durability & tensile strength, and technological advancements of material for human use make it a preferred choice among the medical institutes.
 

From a regional standpoint, Japan vascular graft industry is poised to grow at 7% CAGR through 2027, due to large pool of elderly population who are more susceptible to a variety of ailments, resulting in high demand for vascular grafts.
 

The competitive landscape of the industry is defined by companies such as Becton, Dickinson, and Company, CryoLife, Inc., B. Braun Melsungen AG, Endologix LLC, Cook Group Incorporated, W.L. Gore & Associates, Inc., Getinge AB, Terumo Corporation, LeMaitre Vascular, Inc., and Medtronic plc among others.